Company News

Double live surgery with SmartBone®

September 15th, 2017
SmartBone® Live surgery
The 15th of September in Porto Mantovano (Italy) from 8.30 am, Dr. Roberto Ghiretti will perform a double live surgery using SmartBone® and SmartBone® On Demand™. IBI gives the possibility to assist both live surgeries preceded by a SmartBone® presentation. Specifically during the day you will attend: 1 SmartBone® presentation 1 cyst treated with SmartBone® 1 SmartBone® On Demand augmentation...

Mandibular cystic neoformation treated with SmartBone® – live surgery

July 27th, 2017
The 27th of July in Porto Mantovano (Italy), Dr. Roberto Ghiretti and Dr. Emanuele Ambu will perform a very special surgery: a mandibular cystic neoformation (odontogenus glandular cysts) from 35 to 45 treated with SmartBone®. Below you can find how Dr. Ghiretti and Dr. Ambu will proceed: Root canal therapy of 33, 32 e 43 Cystic...

Large maxillofacial reconstruction case with SmartBone® on Demand™

July 7, 2017
SmartBone® On Demand™
In June 2017, SmartBone® on Demand™  engaged successfully in an enormously complex maxillofacial surgical challenge. The innovative bone substitute designed by the engineers of Industrie Biomediche Insubri SA (IBI-SA) was, in fact, the main star in a severe large maxillo-facial reconstruction case. Thanks to the cooperation between IBI-SA and the renowned Azienda Ospedaliera Universitaria Careggi...

* Important Communication *

--
IBI would like to inform its customers and distributors that a misprint is present in the SmartBone® package insert: the sterilization method of the Medical Device implies the use of ethylene oxide instead of acetylene oxide. IBI regrets for the inconvenience and will promptly take care of...

SmartBone® On Demand™ reconstruction of a large cranial defect

May 31, 2016
In May 2016, SmartBone® on Demand™  engaged successfully in a complex cranial surgical challenge. The innovative bone substitute designed by Industrie Biomedriche Insubri SA was, in fact, the main star in a complex large cranial reconstruction case. Thanks to the cooperation between IBI-SA and the renowned Ospedale Caldarelli in Napoli by Dr. Enzo Facciuto, a revolutionary approach was...

SmartBonePep® a Bio-hybrid composite bone graft

April 6, 2016
smartbonepep
Visit the website! Industrie Biomediche Insubri SA (IBI) in a collaboration with The Pharmaceutical and Biomedical Technologies laboratory, within the Institute CIM for Sustainable Innovation of the University of Applied Sciences and Arts of Southern Switzerland (SUPSI) (www.supsi.ch/icimsi), and Corticalis AS (www.corticalis.com), a Norwegian R&D company focused on bone regenerative technologies and biomaterials, won the Eurostars Project –...

Professor Giuseppe Perale interviewed by Il Caffè magazine

May 5th
Professor Giuseppe Perale,President and founder of IBI Sa, was interviewed by Il Caffè magazine and the subsequent article was published on May 4th, 2014. In the interview, Professor Perale talks about the positive experience lived in Switzerland with his company, Industrie Biomediche Insubri. You can read the whole article at this link. Italian version Il professor...

Smartbone On Demand applied to a post tumoral large spheno-orbital reconstruction

February 14, 2014
In November 2013, Smartbone On Demand engaged successfully in a complex maxillo-facial surgical challenge. The innovative bone substitute designed by Industrie Biomedriche Insubri SA was, in fact, the main star in a complex large spheno-orbital reconstruction case. Thanks to the cooperation between IBI SA and the renowned University of Modena, a revolutionary approach was set...

IBI congratulates Luca Orlando for his Second Degree in Engineering

December 23, 2013
IBI’s Production and R&D Specialist Luca Orlando obtained today his Second Degree in Engineering with a dissertation titled “Analysis of bone cleaning processes of biomedical application”. Luca Orlando’s supervisor was Professor Maurizio Masi while Professor Giuseppe Perale was his co-supervisor. IBI’s exclusive bone substitute Smarbone was the main focus of Orlando’s thesis – as you...

Subscribe to our newsletter